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Abstract  
Thirty-six methicillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from renal 
patients were genetically characterized by DNA microarray analysis and spa typing.  The isolates 
were highly clonal, belonging mainly to ST22-MRSA-IV. The immune evasion and enterotoxin 
gene clusters were found in 29/36 (80%) and 33/36 (92%) of isolates, respectively.  
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Staphylococcus aureus is a frequent cause of bloodstream infections (BSI) worldwide (2, 
3, 17). Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 20-50% of S. aureus 
BSIs in our hospital over the past five years (7). Renal patients are at greater risk of MRSA BSI 
due to impaired immune function, regular contact with healthcare facilities and the presence of 
central venous catheters (CVCs). We investigated the virulence gene profiles of MRSA BSI 
isolates from renal patients by DNA microarray analysis. The study was carried out in Beaumont 
Hospital, Dublin, Ireland, a 820-bed tertiary referral centre harboring the national referral centre 
for renal and pancreatic transplantation, responsible for approximately 200 hemodialysis patients 
at any given time. Many studies have investigated the sources and outcomes of S. aureus 
bacteremia among renal patients, however this is the first study, to our knowledge, to genetically 
characterize MRSA BSI isolates from renal patients (4, 8, 10).  
MRSA BSI isolates from renal patients were prospectively collected from 2005-2009. 
Patient details were collected from EARS-Net data and review of their medical notes.  Genomic 
DNA was extracted using a DNeasy® blood and tissue kit (Qiagen, Crawley, UK). Spa typing, 
which involves PCR amplification and sequencing of the polymorphic 24 base pair variable 
number tandem repeat region within the 3′ end of the protein A gene spa, was carried out 
according to the SeqNet website (http://www.seqnet.org).  Sequencing was performed by 
Beckman Coulter Genomics (Takeley, UK) and Source BioScience (Dublin, Ireland). Genetic 
characterization of isolates was undertaken using the StaphyType Kit (Alere Technologies 
Germany) as previously described (12, 13). The StaphyType Kit is a DNA microarray system 
that detects 334 S. aureus gene sequences including those encoding (i) species markers (nuc, spa, 
coa, femA, gapA, sbi and sarA), (ii) antimicrobial resistance genes (e.g. genes encoding 
resistance to β-lactams, macrolides, tetracyclines, lincosamides, streptogramins, aminoglycosides 
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and glycopeptides), (iii) genes encoding staphylococcal enterotoxins, toxic shock toxin, 
exfoliative toxins, Panton-Valentine leukocidin, the immune evasion complex (IEC) (sak, chp, 
scn, sea and selp) and the arginine catabolic mobile element (ACME), (iv) microbial surface 
components recognizing adhesive matrix molecules (MSCRAMMs), adhesion and biofilm genes 
(e.g. icaA, C and D, cna, fnbA, fnbB, map, cna, ebh, bbp), (v) SCC and SCCmec-associated 
genes and sequences and (vi) capsule (types 1, 5 and 8) and agr (types I-IV) typing markers (13). 
The DNA microarray can also assign S. aureus isolates to multilocus sequence types and/or 
clonal complexes (CCs) (14). 
 Thirty-six MRSA BSI isolates recovered from renal patients (19 female, 17 male) were 
investigated. The median age was 68 and 28 patients (78%) were on hemodialysis. The sources 
of BSI are listed in Table 1. For the majority of patients (26/36; 72.2 %), a CVC was the source 
of BSI. Six patients (16.7 %) developed a secondary focus of infection and these are listed in 
Table 1. The majority of isolates belonged to ST22-MRSA-IV (27/36, 75%) consisting of nine 
spa types with t032 predominating (12/27, 44.4%) (Table 2). Five isolates (5/36, 13.9%) were 
ST5-MRSA-II and spa type t463, three (3/36, 8.3%) were ST8, spa type t190 and harbored 
SCCmec IIE & ccrAB4 or a possible novel SCCmec II subtype and one isolate belonged to 
ST30-MRSA-IV and spa-type t1662. 
  All MRSA BSI isolates from renal patients recovered since 2008 belonged to ST22-
MRSA-IV whereas in the previous three years, 81% belonged to ST22-MRSA-IV with the 
remainder consisting of several minor clones (Table 2). ST22-MRSA-IV is the predominant 
clone in Irish hospitals, accounting for 85% of MRSA BSI isolates in Ireland in 2009 (15). The 
enterotoxin gene cluster egc (seg, sei, sem, sen, seo, seu) was found in all isolates except ST8 
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(33/36, 92 %) isolates. The toxic-shock-toxin (tst) gene was found in all ST5-MRSA-II and 
ST30-MRSA-IV isolates. The gene combination tst, sea, sed, sej and ser, was exclusive to ST5-
MRSA-II isolates and this ST carried more enterotoxin genes than the others. The sec/sel cluster 
was present in a 16/27 (59.3%) ST22-MRSA-IV isolates but in no other STs. The IEC genes are 
important virulence factors of S. aureus (18). An IEC variant was detected in 80% of isolates 
(29/36) including 22/27 (81%) ST22-MRSA-IV, 1/3 (33.3%) ST8 and all ST5-MRSA-II and 
ST30-MRSA-IV isolates (Table 2).  
 We sought to determine the relationship between the genetic characteristics of the 
infecting isolate and the type of infection, infection complications, or clinical outcome. MRSA 
BSI with a ST22-MRSA-IV isolate was a cause of death in one patient. In six patients who 
developed a secondary focus of infection, the infecting isolates belonged to ST22-MRSA-IV 
(4/6, 66.6%) and ST5-MRSA-II (2/6, 33.3%).  Development of a secondary focus of infection 
was not significantly associated with any particular ST, however the highest rate of secondary 
infections involved ST5-MRSA-II (2/5 isolates, 40%) compared to ST22-MRSA-IV (4/27 
isolates, 15%). This clone carried the most enterotoxin genes including sea and has been shown 
to be significantly associated with more severe S. aureus infection (1, 5, 6).  Interestingly, the 
ST5-MRSA-II isolates harbored more antimicrobial resistance genes than ST22-MRSA-IV, but 
ST8 isolates harbored the greatest number of resistance genes (Table 2). The antibiotic resistant 
genes fosB and tetefflux were present in ST5-MRSA-II, ST8 and ST30 isolates. While nine of the 
MSCRAMM, adhesion and biofilm genes investigated were detected in all isolates, only ST22-
MRSA-IV and ST30-MRSA-IV isolates harbored the collagen binding adhesin gene cna and 
lacked the genes encoding the fibrinogen binding protein fib and fibronectin binding protein fnbB 
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(Table 2). ST22-MRSA-IV isolates also lacked the extracellular matrix binding protein ebh 
(Table 2).  
Recent characterization of other S. aureus isolate collections indicates a strong clonal 
association of virulence genes including the egc cluster and IEC variants (11, 16) and these 
correlations were also evident in the present study. The correlation between carriage of specific 
virulence genes and clinical outcome remains unclear because host factors are also involved. For 
example, there is evidence for negative or positive correlation between egc gene carriage and 
infection severity in different isolate collections (5, 9) but how these genes limit or contribute to 
clinical complications is difficult to establish. Virulence gene expression may also affect the 
clinical outcome but it is technically challenging to reliably determine gene expression that 
reflects the in vivo setting.  The detailed characterization of virulence genes described here 
supports the clonal distribution of virulence-associated genes in a specific patient group with 
increased risk for multiple episodes of S. aureus infection. Although the small sample size 
excludes a statistically robust evaluation of the relationship between virulence gene carriage and 
clinical outcome, carriage of egc genes at least, is apparently independent of the development of 
clinical complications in these patients.   
 In conclusion, this is the first report of MRSA BSI isolates in renal patients that have 
been typed and characterized in detail using DNA microarray. DNA microarray analysis is a 
useful, rapid and convenient tool for more comprehensive analysis of virulence and antimicrobial 
resistance genes in S. aureus.   
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TABLE 1.  Infection types found in renal patients with MRSA bloodstream infections 
(BSIs) in the present study 
 
Infection type 
 
Number of isolates (%) 
 
Source of BSI 
Central venous catheter 
Skin and soft tissue infection 
Infected peripheral vascular catheter 
Infective endocarditis 
Surgical site infection 
Intra-abdominal infection 
Not identified 
 
Secondary foci of infection 
Osteomyelitis 
Infective endocarditis 
Implantable cardiac rhythm device 
 
 
 
26 (72.2)  
2  (5.6) 
2 (5.6) 
1 (2.8) 
1 (2.8)  
1 (2.8)  
3 (8.3) 
 
 
1 (2.8) 
3 (8.3) 
2 (5.6) 
 
 
   
  
 
1 
 
1 
2 
TABLE 2. Molecular characteristics of 36 MRSA bloodstream isolates from renal patients 
recovered between 2005 and 2009 
ST SCCmec 
type (n) 
spa types (n) agr/ 
capsule 
type 
Antimicrobial 
resistance genesa 
Virulence-
associated genesa  
MSCRAMM, 
adhesion & 
biofilm genesa 
ST22 IV (27) t025(1), 
t032(12), 
t515(3), 
t557(3), 
t1214(3), 
t2945(2), 
t3185(1), 
t5420(1), 
t7636(1) 
I/5 erm(C) (21), 
lnu(A)/aacA-
aphD/aadD/mupA (1) 
seb (2), sec/l (16), 
egc, sak/chp/scn 
(22; IEC type B), 
ACME (1) 
bbp (25), cna, 
map, sdrC, sdrD 
(26), sasG 
ST5 II (5) t463 (5) II/5 erm(A), aadD, 
tetefflux, fosB, merA & 
merB (1) 
tst, sed/j/r, egc, 
sea/sak/chp/scn 
(IEC type A)  
bbp, ebh, fib, 
fnbB, map, sdrC, 
sdrD, sasG 
ST8 IIE & 
ccrAB4 (2) 
Novel II 
subtype (1)b 
t190 (3) I/5 erm(A), tetefflux, fosB, 
qacA, aacA-aphD, 
aadD/aphA3-sat (2), 
merA & merB (2) 
sea/sak/scn (IEC 
type D) 
bbp, ebh, fib, fnbB 
(2), map (2), sdrD 
  
ST30 IV (1) t1662 (1) III/8 Q6GD50 (fusC), 
tetefflux, fosB 
tst, egc, 
sak/chp/scn (IEC 
type B) 
bbp, cna, ebh, fib, 
map, sdrC, sdrD  
 
a The number of positive isolates are indicated in parenthesis if not all isolates within a genotype 
were positive for the gene indicated. All isolates harbored the beta-lactamase resistance gene 
blaZ and the MSCRAMM, adhesion and biofilm genes icaA, icaC & icaD, clfA & clfB, ebpS, 
eno, fnbA and vwb. 
3 
4 
5 
6 
7 
8 
9 
10 
bPossible novel SCCmec II subtype identified in one ST8 MRSA isolate that yielded signals for 
class A mec complex, ccrAB2 but lacked signals for kdp and aadD (pUB110).  
 
 
